Indoles, which could inhibit various enzymes and receptors, such as HDAC, proviral insertion site in moloney murine leukemia virus (Pim), and tubulin in cancer cells, are scaffolds to avail for developing novel anticancer agents (Guo and Diao, 2020; Xu and Xu, 2020). This evidence concerns the gene HDAC9 and cancer.